248 research outputs found
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
Get PDFThere is a need to develop and validate biomarkers for treatment response and survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response score (CRS) stratifies patients into complete/near-complete (CRS3), partial (CRS2), and no/minimal (CRS1) response after neoadjuvant chemotherapy (NACT). Our aim was to review current evidence to determine whether the CRS is prognostic in women with tubo-ovarian HGSC treated with NACT.This article is freely available via Open Access. Click on the Publisher URL to access the full-text via the publisher's site
ChemInform Abstract: Synthesis and Restricted Furanose Conformations of Three Novel Bicyclic Thymine Nucleosides: A xylo-LNA Nucleoside, a 3′-O,5′-C-Methylene-Linked Nucleoside, and a 2′-O,5′-C-Methylene-Linked Nucleoside.
No full text
- …
